Effect of intravitreal bevacizumab for retinopathy of prematurity on weight gain.

ABSTRACT:

Purpose

To evaluate the short-term effect on body weight (BW) gain after intravitreal bevacizumab (IVB) for retinopathy of prematurity (ROP).

Methods

This was a retrospective 1:1 matched case-control study. Infants with ROP treated by IVB or photocoagulation (PC) at Shiga University of Medical Science Hospital between April 2010 and December 2019 were included in the study. To match BWs at treatment between the IVB and PC groups, 1:1 matching for BWs at treatment within 100 g was performed. The BW gains for the 7 days before treatment (pre-treatment week), the 7 days after treatment (first post-treatment week), and the period from 7 to 14 days after treatment (second post-treatment week) were compared between the IVB and PC groups.

Results

Following 1:1 matching, 13 i

SUBMITTER: Obata S 

PROVIDER: S-EPMC8664189 | biostudies-literature | 2021

REPOSITORIES: biostudies-literature